BioSpace News Archive

Business

Syros to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018

Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, August 7, 2018 to report its second quarter 2018 financial results and provide a corporate update.

July 31, 2018
·
1 min read
Business

Cardiovascular Systems, Inc. and Aerolase Corp. Sign Collaborative Agreement for Laser Atherectomy Technology

Cardiovascular Systems, Inc. today announced that it has signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device for physicians to use in more effectively treating multiple forms of arterial disease.

July 31, 2018
·
4 min read
Genetown

Pear Therapeutics to Present at Canaccord Genuity 38th Annual Growth Conference

Pear Therapeutics, Inc. will present at the Canaccord Genuity 38th Annual Growth Conference on Thursday, August 9th at 10:30 a.m. at the InterContinental Boston.

July 31, 2018
·
1 min read
Drug Development

Kala Pharmaceuticals Announces Dosing of First Patient in Phase 3 STRIDE 3 Trial of KPI-121 0.25% in Patients with Dry Eye Disease

Phase 3 trial of KPI-121 0.25% for the short-term treatment of dry eye disease.

July 31, 2018
·
8 min read
Business

Generation Bio Appoints Charles Rowland to its Board of Directors

Generation Bio is a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit.

July 31, 2018
·
2 min read
Business

Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call

Second Sight Medical Products, Inc. will release its 2018 second quarter financial results on Tuesday, August 7, 2018, after the close of the U.S. financial markets.

July 31, 2018
·
5 min read
Business

CANbridge Life Sciences Appoints Chief Medical Officer

Dr. Orfali replaced Dr. Mark Goldberg, who was acting as interim Chief Medical Officer.

July 31, 2018
·
5 min read
Business

Hadassah Medical Center Joins TriNetX to Increase Clinical Trial Collaboration Efforts with Pharma

Hadassah Medical Center to join the TriNetX global health research network to increase clinical trial activity and help pharmaceutical companies improve the protocol design and feasibility process.

July 31, 2018
·
3 min read
Policy

MerLion Regains North American Rights to XTOROTM FDA-Approved Antibiotic for Treatment of Ear Infections

MerLion Pharmaceuticals announced that Novartis has made a portfolio decision and terminated the license between Alcon (a subsidiary of Novartis) and MerLion executed in 2010 and returned all rights to MerLion. MerLion now owns all rights to XTORO™ globally.

July 31, 2018
·
3 min read
DouxMatok and Südzucker Announce Partnership to Manufacture and Commercialize Breakthrough Sugar Reduction Technology Across Europe

Addressing both industry and consumer’s needs, a key priority is to drive launches of new products with substantially less sugar and with no taste compromises

July 31, 2018
·
5 min read